Molecular heterogeneity in human beta-galactosidase and neuraminidase deficiency.
Human lysosomal beta-galactosidase and neuraminidase exist in a complex together with a 32-kilodalton (kd) glycoprotein. The latter protein was found to have a dual function: it is required for the aggregation of monomeric 64-kd beta-galactosidase into high molecular weight (600-700 kd) multimers and it is an essential subunit of neuraminidase together with a 76-kd polypeptide. The severe neurological disorder galactosialidosis, characterized by a coexistent deficiency of beta-galactosidase and neuraminidase, was found to be due to a genetic defect of the 32-kd protective protein. The molecular background of the clinical heterogeneity within this syndrome is described and will undoubtedly be further elucidated since we have recently isolated the gene coding for the protective protein. The sequence of normal and mutant (enzyme) proteins will also provide better insight into the characteristics of the beta-galactosidase-neuraminidase-protective protein complex. Another interesting model for the study of posttranslational processing is the defective phosphorylation of beta-galactosidase in cells from patients with GM1-gangliosidosis.
D000818:Animals; D005696:Galactosidases / Q000235:genetics*; D005733:Gangliosidoses / Q000201:enzymology; D006801:Humans; D008967:Molecular Biology; D008970:Molecular Weight; D009154:Mutation; D009439:Neuraminidase / Q000096:biosynthesis / Q000172:deficiency / Q000235:genetics*; D001616:beta-Galactosidase / Q000096:biosynthesis / Q000172:deficiency / Q000235:genetics*
D005696:Galactosidases; D009439:Neuraminidase; D001616:beta-Galactosidase